Equity Overview
Price & Market Data
Price: $0.227
Daily Change: -$0.0113 / 4.98%
Daily Range: $0.21 - $0.248
Market Cap: $7,113,801
Daily Volume: 6,960,020
Performance Metrics
1 Week: -52.79%
1 Month: -67.99%
3 Months: -79.37%
6 Months: -93.14%
1 Year: -98.02%
YTD: -62.46%
Company Details
Employees: 3
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.